SCHEMBL21046107

SCHEMBL21046107

Cc1cc(-c2ccc(-c3ccc(-c4ccc(-n5c6ccc(N(c7ccccc7)c7ccccc7)cc6c6cc(N(c7ccccc7)c7ccccc7)ccc65)cc4)cc3)cc2)cc(C)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 1/20 0.36
▸ SIRT2 Q8IXJ6 2/20 0.35
▸ SIRT1 Q96EB6 2/20 0.35
▸ MAPT P10636 4/20 0.33
▸ MEN1 O00255 4/20 0.33
▸ KMT2A Q03164 4/20 0.33
▸ SMN1; SMN2 Q16637 4/20 0.33
▸ L3MBTL1 Q9Y468 3/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ PTGER4 P35408 1/20 0.33
▸ XBP1 P17861 1/20 0.33
▸ NTSR1 P30989 1/20 0.33
▸ KDM4E B2RXH2 5/20 0.33
▸ ALDH1A1 P00352 5/20 0.33
▸ GFER P55789 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ AVPR1A P37288 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ HPGD P15428 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20088707 0.88 KDM4E (0.41) APPSIRT2SIRT1MAPTMEN1
SCHEMBL9912827 0.86 L3MBTL1 (0.40) APPSIRT2SIRT1MAPTMEN1
SCHEMBL12559422 0.86 L3MBTL1 (0.40) APPSIRT2SIRT1MAPTMEN1
SCHEMBL21085411 0.85 CRHR1 (0.33) MAPTMEN1KMT2ASMN1; SMN2L3MBTL1
SCHEMBL20412912 0.85 CYP19A1 (0.36) SIRT2SIRT1MAPTMEN1KMT2A
SCHEMBL21046157 0.85 CYP19A1 (0.36) SIRT2SIRT1MAPTMEN1KMT2A
SCHEMBL20412963 0.85 CYP19A1 (0.36) SIRT2SIRT1MAPTMEN1KMT2A
SCHEMBL17897467 0.84 ALDH1A1 (0.36) APPSIRT2SIRT1MAPTMEN1
SCHEMBL15785793 0.84 ALDH1A1 (0.36) APPSIRT2SIRT1MAPTMEN1
SCHEMBL21587121 0.83 KDM4E (0.44) APPSIRT2SIRT1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190173017-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-06-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190173017-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, ALDH1A2, CYBA APP 1609/4885SIRT2 2282/4885SIRT1 3059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback